Brilliant Board Review & CME

🎙️ Brilliant Medicine: Your Internal Medicine Edge Stay sharp, stay current, and stay confident with Brilliant Medicine — the go-to podcast for Internal Medicine and Family Medicine physicians, residents, nurse practitioners, and physician assistants. Each episode delivers high-yield insights on the latest breakthroughs , practice-changing guidelines , and cutting-edge treatments in Internal Medicine — with just enough board review to keep your clinical reasoning razor-sharp. We cut through the noise, simplify complex studies, and translate new data into actionable knowledge for your daily practice. Whether you're prepping for boards or staying ahead in clinic, hospital, or telemed — we've got your back. 🩺 Fast. Practical. Evidence-based. This is the update your medical brain craves.

Brilliant Board Review & CME is a education podcast hosted by Unknown Host, with 45 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Brilliant Board Review & CME, a education show with 45 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #42

  🎙️ Episode 42: DOACs Decoded: When to Dabble, When to Dodge

  Apr 21, 20253 minS1

  <p>Send us a text</p><p>🧠 Clinical Context</p><p>DOACs (Direct Oral Anticoagulants) have revolutionized anticoagulation—goodbye routine INRs, hello convenience. But while they’ve made our lives easier, they’re not always a fit for every scenario. Here's how to navigate the DOAC jungle.</p><p>✅ When DOACs Are Preferred</p><b>Venous Thromboembolism (VTE)</b><b>Atrial Fibrillation</b>⚠️ <b>Exclude</b> patients with:Mechanical heart valvesRheumatic mitral valve disease<br/> (That’s why cardiologists note “non-rheumatic” AF in their documentation—treatment plan hinges on it.)<p>⛔ When DOACs Are a No-Go</p><b>Mechanical Heart Valves</b> → Warfarin only...

  ListenShow Notes
• 

  Episode #45

  🎙️ Episode 45: Mind the Gap – Perioperative Pearls for Older Adults

  Apr 21, 20252 minS1

  <p>Send us a text</p><p>🧠 Clinical Context</p><p>Patients over 65 undergoing <b>inpatient surgery</b> face unique risks. Cognitive impairment, frailty, and increased vulnerability to delirium demand a proactive and nuanced approach to anesthesia and postoperative care.</p><p>🔍 Preoperative Priorities</p><b>Age ≥65</b> and <b>inpatient status</b> should automatically trigger a <b>frailty and cognitive assessment</b>Engage a <b>multidisciplinary team</b> early—geriatrics, anesthesia, surgery, and nursing<p>🛌 Postoperative Delirium: A Common Pitfall</p>Use <b>dexmedetomidine</b> in the PACU or ICU setting for sedation/delirium prevention<b>Avoid these culprits</b>:Benzodiaze...

  ListenShow Notes
• 

  Episode #43

  🎙️ Episode 43: GLP-1s Under the Knife – A Gut Check on Surgery Risks

  Apr 21, 20252 minS1

  <p>Send us a text</p><p>🧠 Clinical Context</p><p>GLP-1 receptor agonists have taken center stage for both <b>type 2 diabetes</b> and <b>obesity management</b>, but their <b>gastric side effects</b> are giving anesthesiologists pause. The ASA's recent guidance recommends holding these agents before surgery to reduce risks of <b>gastroparesis</b>, <b>regurgitation</b>, and <b>pulmonary aspiration</b>.</p><p>🔬 ASA Guidelines Overview</p><b>Daily Dosing?</b> Hold on the day of surgery<b>Weekly Dosing?</b> Hold one week prior<b>If asymptomatic and held as above?</b> Proceed as usual<p>⚠️ B...

  ListenShow Notes
• 

  Episode #44

  🎙️ Episode 44: Thiazide Throwdown: HCTZ vs Chlorthalidone in Real Life

  Apr 21, 20253 minS1

  <p>Send us a text</p><p>🧠 Clinical Context</p><p>Hydrochlorothiazide (HCTZ) vs. Chlorthalidone—a classic cardio debate! ALHAT once hinted at chlorthalidone’s superiority, but did a modern head-to-head trial confirm that? Let's break it down.</p><p>🧪 Study Snapshot: The HEADS-UP Trial</p><b>Design:</b> Randomized, head-to-head trial<b>Population:</b> ~14,000 patients, age ≥65, already on HCTZ 25–50 mg + 1–2 antihypertensives<b>Prior CV disease:</b> 15% had MI, stroke, or HF<b>Groups:</b>Continue <b>HCTZ</b>Switch to <b>Chlorthalidone</b> 12.5–25 mg daily<b>Follow-up:</b> Median 2.4 years<p>📈 Outcomes</p><b>Primary endpoint:</b> Composite of MI, stroke, HF, urgen...

  ListenShow Notes
• 

  Episode #41

  🎙️ Episode 41: Stairway to Surgery: Cardiac Clues Before the Cut

  Apr 21, 20252 minS1

  <p>Send us a text</p><p>🧠 Clinical Context:</p><p>You're prepping a patient for <b>non-cardiac surgery</b>—what's their cardiovascular risk? Turns out, it’s not always about echo reports or cath results. It starts with a <b>stairs test</b> (sort of).</p><b>Duke Activity Status Index (DASI)</b> and <b>METs >4</b> can tell you if the heart's got enough reserve.🚶‍♂️ <b>“Can you walk up a flight of stairs without gasping?”</b> If yes, you’re likely good to go!If <b>functional status is poor or unknown</b>, consider labs:<b>BNP, pro-BNP, or troponin<...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.